Synonyms: Bexxar® | V10XA53
tositumomab is an approved drug (FDA (2003))
Compound class:
Antibody
Comment: Tositumomab was used as a radioimmunotherapy drug, targeting CD20 on B-lymphocytes prior to cessation of its manufacture.
|
Bioactivity Comments |
We have been unable to find any publicly available affinity value for the interaction between tositumomab and its antigen, CD20. The patent covering the use of radioactively-labelled anti-CD20 antibodies [2] refers back to articles and abstracts published in the early 1980's [1,3], none of which provide affinity data. |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|